Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 25 for “"demethylating agents"”.

  1. Low dose demethylating agents in oral cancer And The respiratory phenotype of Phd1 -/- mouse liver mitochondria

    … in cancer. 5-Aza2’ deoxycytidine (DAC) is a demethylating agent used in the treatment of haematological malignancies with research suggesting that the treatment may be transferable to solid tumours. High doses have proved toxic however low doses may provide the benefits of demethylation …

    birmingham Download PDF for Low dose demethylating agents in oral cancer And The respiratory phenotype of Phd1 -/- mouse liver mitochondria (opens in a new tab)

  2. Functional genetic characterization of acute myeloid leukemia using demethylating agents, RNA interference and genome editing technologies

    Die akute myeloische Leukämie ist eine genetisch heterogene Erkrankung der Myelopoese, die vor allem Patienten im höheren Alters betrifft. Chromosomale Aberrationen sowie genetische Mutationen führen zur unregulierten klonalen Vermehrung hämatopoetischer Vorläufer- und Stammzellen. Die wichtigste …

    freiburg-diss Repository record for Functional genetic characterization of acute myeloid leukemia using demethylating agents, RNA interference and genome editing technologies (opens in a new tab)

  3. 6-Thioguanine and zebularine globally demethylate a canine lyphoma cell line

    … we evaluated a cells in vitro, exposing them to demethylating agents. Our end analysis was generation of cell proliferation and viability assays, quantitation of global methylation levels, and confirmation of demethylating drug targets. We hypothesized that canine lymphoma cells will undergo …

    missouri Repository record for 6-Thioguanine and zebularine globally demethylate a canine lyphoma cell line (opens in a new tab)

  4. Regulatory T cells in rheumatoid arthritis: the role of TNF-α receptor signaling and DNA methylation

    … I investigated the therapeutic potential of DNA demethylating agents in the treatment of RA. It showed that the DNA demethylating drug, decitabine, ameliorated collagen-induced arthritis (an animal model of rheumatoid arthritis) and promoted Treg suppressive function whilst inhibiting pathogenic …

    oxford Repository record for Regulatory T cells in rheumatoid arthritis: the role of TNF-α receptor signaling and DNA methylation (opens in a new tab)

  5. EPIGENETIC THERAPY TIES MYC DEPLETION TO REVERSING IMMUNE EVASION AND TREATING LUNG CANCER

    Combining DNA demethylating agents (DNMTis) with histone deacetylase inhibitors (HDACis) holds promise for enhancing cancer immune therapy. Herein, pharmacologic and isoform specificity of HDACi’s are investigated to guide their addition to a DNMTi, thus devising a new, low-dose, sequential regimen …

    jhu Repository record for EPIGENETIC THERAPY TIES MYC DEPLETION TO REVERSING IMMUNE EVASION AND TREATING LUNG CANCER (opens in a new tab)

  6. RNA APPROACH FOR GENE SPECIFIC DEMETHYLATION AND ACTIVATION

    … genes. Currently, low toxicity and gene-specific demethylating agents are still missing. In this thesis, we successfully developed CRISPR-DiR as a gene specific demethylation and activation tool, in which DNMT1-interacting RNAs (DiRs) loops are fused to CRISPR sgRNA and are delivered to a specific …

    nus Repository record for RNA APPROACH FOR GENE SPECIFIC DEMETHYLATION AND ACTIVATION (opens in a new tab) Download file for RNA APPROACH FOR GENE SPECIFIC DEMETHYLATION AND ACTIVATION (opens in a new tab)

  7. Investigating the pathogenesis and therapy of Friedreich Ataxia

    … the efficacy and tolerability of various DNA demethylating agents, GAA interacting compounds and class III histone deacetylase (HDAC) inhibitors. Although DNA demethylating agents showed increased FXN expression, no correlation between the level of DNA methylation and FXN expression was …

    brunel Repository record for Investigating the pathogenesis and therapy of Friedreich Ataxia (opens in a new tab)

  8. Molecular response factors of demethylating therapy in AML

    … AML. However, the mechanism of action of the two demethylating agents in AML and putative response modulators remain unknown. Furthermore, reliable biomarkers of therapy response to these drugs do not yet exist and patients initially responding develop resistant disease at the latest after two …

    freiburg-diss Repository record for Molecular response factors of demethylating therapy in AML (opens in a new tab)

  9. Exploring promoter silencing and re-expression of SH3GL2/endophilin A1 in urothelial cancer

    … of the SH3GL2 promoter and to test whether agents that promote Deoxyribonucleic acid (DNA) demethylation could be used to re-express SH3GL2 thereby restoring regulation of RTK signaling. METHODS: Methylation of a specific CpG island in the SH3GL2 promoter was analyzed using …

    bu Repository record for Exploring promoter silencing and re-expression of SH3GL2/endophilin A1 in urothelial cancer (opens in a new tab)

  10. MODELING AND THERAPEUTIC TARGETING OF ENDOGENOUS IDH1-MUTANT GLIOMA

    … and mechanism of action of the FDA approved demethylating drug 5-azacytidine. Long term administration of 5-azacytidine resulted in reduction of DNA methylation of promoter loci, induction of glial differentiation, reduction of cell proliferation and a significant reduction in tumor growth. …

    jhu Repository record for MODELING AND THERAPEUTIC TARGETING OF ENDOGENOUS IDH1-MUTANT GLIOMA (opens in a new tab)

  11. Combination treatments in <i>in vitro</i> and <i>in vivo</i> models between molecules reverting epigenetic gene silencing and DNA-interacting anticancer drugs

    … prostate cancer, based on the combination of demethylating agents and brostallicin, a DNA minor groove binding drug, which is activated in the cell by binding to glutathione, a reaction catalyzed by GST. <br></br><br></br>Among the demethylating molecules tested on the prostatic cancer cell …

    the-open-u Download PDF for Combination treatments in <i>in vitro</i> and <i>in vivo</i> models between molecules reverting epigenetic gene silencing and DNA-interacting anticancer drugs (opens in a new tab)

  12. Characterisation of the innate immune sensor MDA5

    … in the context of cancer treatment with DNA demethylating agents, and in autoinflammatory and autoimmune diseases. In all these settings, physiological MDA5 agonists have not been identified. To identify MDA5-stimulatory RNAs, we generated mouse monoclonal antibodies against human MDA5. We …

    oxford Repository record for Characterisation of the innate immune sensor MDA5 (opens in a new tab)

  13. Gene-specific demethylation and re-activation of tumor suppressors in acute myeloid leukemia via a novel RNA-mediated platform

    … suppressor gene CDKN2B. Currently available demethylating agents, namely 5-azacytidine and 5-aza-2’-deoxycytidine, are used to treat acute myeloid leukemia and inhibit DNA methyltransferases either by direct binding or by incorporation into DNA as nucleoside analogs. While effective, they are …

    bu Repository record for Gene-specific demethylation and re-activation of tumor suppressors in acute myeloid leukemia via a novel RNA-mediated platform (opens in a new tab)

  14. Dynamic epigenetic modifications during human fetal germ cell development

    … fetal gonads, showed that treatments with DNA demethylating agents are linked to the activation and increase of post-migratory germ cell-specific genes along with meiotic genes in human. To conclude, the results from this study demonstrate that epigenetic changes, such as histone modification …

    edinburgh Repository record for Dynamic epigenetic modifications during human fetal germ cell development (opens in a new tab)

  15. Investigating The Impact of Intragenic Dna Methylation On Gene Expression, and The Clinical Implications On Tumor Cells and Associated Stroma

    … expression can be abrogated by treatment with demethylating agents. These findings implicate the 3’UTR as a functionally relevant DNA methylation site, particularly regarding T cell activity. Additionally, they reveal a novel mechanism by which HAVCR2 is upregulated in T cells, providing a new …

    uthsc Repository record for Investigating The Impact of Intragenic Dna Methylation On Gene Expression, and The Clinical Implications On Tumor Cells and Associated Stroma (opens in a new tab)

  16. Bixin biosynthesis in annatto (Bixa orellana L.) leaves cultured in vitro: influence of irradiance, spectral light quality and the methyltransferase inhibitor 5-azacytidine

    … and apocarotenoids accumulation. Treatments with demethylating agents, such as 5-azacytidine (5-AZA) were previously related to an increased production of secondary compounds and used to study secondary metabolism pathways in plants. The light are characterized by irradiance, wavelength or quality …

    brazil-ufv Repository record for Bixin biosynthesis in annatto (Bixa orellana L.) leaves cultured in vitro: influence of irradiance, spectral light quality and the methyltransferase inhibitor 5-azacytidine (opens in a new tab)

  17. Characterisation of the role of KLF5 in normal haemopoiesis and acute myeloid leukaemia.

    … that treatment of leukaemia cell lines with demethylating agents re-activates KLF5 expression in cells displaying hypermethylation of KLF5. Aberrant methylation of the KLF5 proximal promoter is associated with samples displaying monosomy 7 or deletions in chromosome 7q, and methylation of …

    adelaide Repository record for Characterisation of the role of KLF5 in normal haemopoiesis and acute myeloid leukaemia. (opens in a new tab)

  18. Induced Pluripotent stem cells as a model system to study disease progression in myelodysplastic syndromes

    … strategies in high-risk patients include demethylating agents and cytotoxic drugs, however, 50-60% of these patients do not respond to the treatment and progress to the worst stage. Therefore, there is an unmet clinical need to better understand the mechanisms leading to these blood …

    birmingham Download PDF for Induced Pluripotent stem cells as a model system to study disease progression in myelodysplastic syndromes (opens in a new tab)

  19. Epigenetics in cancer : basic and translational aspects.

    … as anti-cancer therapies in the clinic. Existing demethylating agents have poor pharmacological properties that limit their clinical use, and the application of nano-based encapsulation to resolve these issues is discussed. Chapter 2, submitted as an original research article to Biodrugs, presents …

    adelaide Repository record for Epigenetics in cancer : basic and translational aspects. (opens in a new tab)

Page 1 of 2